...
bjdx-img

Bluejay Diagnostics Inc, Common Stock

BJDX

NAQ

$3.89

-$0.28

(-6.71%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.31M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
43.28K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.03 L
$1260 H
$3.89

About Bluejay Diagnostics Inc, Common Stock

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameBJDXSectorS&P500
1-Week Return1.71%-3.39%-3.47%
1-Month Return11.8%-3.25%-0.29%
3-Month Return-44.03%-11.61%4.5%
6-Month Return-97.16%-5.89%6.91%
1-Year Return-99.64%2.65%23.79%
3-Year Return-99.98%0.56%28.43%
5-Year Return-99.99%34.63%83.64%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--75.00249.04K-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue142.97K157.04K145.72K200.13K780.96K[{"date":"2019-12-31","value":18.31,"profit":true},{"date":"2020-12-31","value":20.11,"profit":true},{"date":"2021-12-31","value":18.66,"profit":true},{"date":"2022-12-31","value":25.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(142.97K)(157.04K)(145.72K)48.91K(780.96K)[{"date":"2019-12-31","value":-292.32,"profit":false},{"date":"2020-12-31","value":-321.07,"profit":false},{"date":"2021-12-31","value":-297.93,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1596.69,"profit":false}]
Gross Margin--(194292.00%)19.64%-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-989276.03,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses1.63M1.20M3.16M9.37M10.31M[{"date":"2019-12-31","value":15.82,"profit":true},{"date":"2020-12-31","value":11.6,"profit":true},{"date":"2021-12-31","value":30.6,"profit":true},{"date":"2022-12-31","value":90.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.63M)(1.20M)(3.23M)(9.32M)(10.31M)[{"date":"2019-12-31","value":-163141300,"profit":false},{"date":"2020-12-31","value":-119639100,"profit":false},{"date":"2021-12-31","value":-323016300,"profit":false},{"date":"2022-12-31","value":-931777600,"profit":false},{"date":"2023-12-31","value":-1031121600,"profit":false}]
Total Non-Operating Income/Expense863.86K11.11K(625.59K)(77.09K)522.23K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":1.29,"profit":true},{"date":"2021-12-31","value":-72.42,"profit":false},{"date":"2022-12-31","value":-8.92,"profit":false},{"date":"2023-12-31","value":60.45,"profit":true}]
Pre-Tax Income(819.84K)(1.16M)(3.49M)(9.30M)(9.95M)[{"date":"2019-12-31","value":-81984200,"profit":false},{"date":"2020-12-31","value":-115828500,"profit":false},{"date":"2021-12-31","value":-348829800,"profit":false},{"date":"2022-12-31","value":-929694800,"profit":false},{"date":"2023-12-31","value":-995388800,"profit":false}]
Income Taxes(62.13K)(32.57K)241.39K(69.06K)5.00[{"date":"2019-12-31","value":-25.74,"profit":false},{"date":"2020-12-31","value":-13.49,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-28.61,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(757.72K)(1.13M)(3.73M)(9.23M)(9.95M)[{"date":"2019-12-31","value":-75771600,"profit":false},{"date":"2020-12-31","value":-112571600,"profit":false},{"date":"2021-12-31","value":-372968600,"profit":false},{"date":"2022-12-31","value":-922788900,"profit":false},{"date":"2023-12-31","value":-995389300,"profit":false}]
Income From Continuous Operations(819.84K)(1.16M)(3.49M)(9.30M)(10.04M)[{"date":"2019-12-31","value":-81984200,"profit":false},{"date":"2020-12-31","value":-115828500,"profit":false},{"date":"2021-12-31","value":-348829800,"profit":false},{"date":"2022-12-31","value":-929694800,"profit":false},{"date":"2023-12-31","value":-1003740000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(757.72K)(1.13M)(3.73M)(9.23M)(9.95M)[{"date":"2019-12-31","value":-75771600,"profit":false},{"date":"2020-12-31","value":-112571600,"profit":false},{"date":"2021-12-31","value":-372968600,"profit":false},{"date":"2022-12-31","value":-922788900,"profit":false},{"date":"2023-12-31","value":-995388800,"profit":false}]
EPS (Diluted)(0.02)(0.14)(0.39)(0.47)(6.81)[{"date":"2019-12-31","value":-2.45,"profit":false},{"date":"2020-12-31","value":-13.67,"profit":false},{"date":"2021-12-31","value":-39.3,"profit":false},{"date":"2022-12-31","value":-47,"profit":false},{"date":"2023-12-31","value":-681,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BJDX
Cash Ratio 5.49
Current Ratio 6.26

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BJDX
ROA (LTM) -58.51%
ROE (LTM) -125.25%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BJDX
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BJDX
Trailing PE NM
Forward PE NM
P/S (TTM) 54.99
P/B 0.33
Price/FCF NM
EV/R 5.67
EV/Ebitda NM

FAQs

What is Bluejay Diagnostics Inc share price today?

Bluejay Diagnostics Inc (BJDX) share price today is $3.89

Can Indians buy Bluejay Diagnostics Inc shares?

Yes, Indians can buy shares of Bluejay Diagnostics Inc (BJDX) on Vested. To buy Bluejay Diagnostics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BJDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bluejay Diagnostics Inc be purchased?

Yes, you can purchase fractional shares of Bluejay Diagnostics Inc (BJDX) via the Vested app. You can start investing in Bluejay Diagnostics Inc (BJDX) with a minimum investment of $1.

How to invest in Bluejay Diagnostics Inc shares from India?

You can invest in shares of Bluejay Diagnostics Inc (BJDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in BJDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bluejay Diagnostics Inc shares
What is Bluejay Diagnostics Inc 52-week high and low stock price?

The 52-week high price of Bluejay Diagnostics Inc (BJDX) is $1260. The 52-week low price of Bluejay Diagnostics Inc (BJDX) is $3.03.

What is Bluejay Diagnostics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bluejay Diagnostics Inc (BJDX) is

What is Bluejay Diagnostics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bluejay Diagnostics Inc (BJDX) is 0.33

What is Bluejay Diagnostics Inc dividend yield?

The dividend yield of Bluejay Diagnostics Inc (BJDX) is 0.00%

What is the Market Cap of Bluejay Diagnostics Inc?

The market capitalization of Bluejay Diagnostics Inc (BJDX) is $2.31M

What is Bluejay Diagnostics Inc’s stock symbol?

The stock symbol (or ticker) of Bluejay Diagnostics Inc is BJDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top